Skip to main content
Genmab logo

Genmab — Investor Relations & Filings

Ticker · GMAB ISIN · DK0010272202 LEI · 529900MTJPDPE4MHJ122 CO Manufacturing
Open in API
Filings indexed 2,823 across all filing types
Latest filing 2016-09-28 Major Shareholding Noti…
Country DK Denmark
Listing CO GMAB

About Genmab

https://www.genmab.com/

Genmab is an international biotechnology company that specializes in the creation, development, and commercialization of differentiated antibody therapeutics. The company focuses on transforming the treatment of cancer and other serious diseases. By utilizing proprietary antibody technology platforms and scientific expertise, Genmab develops a pipeline of innovative medicines. Its activities span from discovery and research through clinical development to deliver novel therapies to patients.

Recent filings

Filing Released Lang Actions
Storaktionærmeddelelse
Major Shareholding Notification Classification · 100% confidence The document is titled 'Storaktionærmeddelelse' (Major Shareholder Announcement) and explicitly references 'Værdipapirlovens paragraf 29' (Section 29 of the Securities Trading Act), which relates to the disclosure of major shareholdings. It details a correction to a previous notification regarding the percentage of voting rights held by Baillie Gifford & Co in Genmab A/S. This fits the definition of a Major Shareholding Notification (MRQ).
2016-09-28 English
Storaktionærmeddelelse
Major Shareholding Notification Classification · 95% confidence The document is a statutory notification under the Danish Securities Trading Act (Værdipapirlovens §29) by Baillie Gifford & Co correcting its prior disclosure of its indirect ownership percentage in Genmab A/S. This is a change in significant shareownership level and falls squarely under Major Shareholding Notification (MRQ).
2016-09-28 Danish
Share Issue/Capital Change 2016
Share Issue/Capital Change Classification · 99% confidence The document is titled 'Selskabsmeddelelse' (Company Announcement) and details a specific corporate action: an increase in share capital ('forhøjer selskabets aktiekapital') resulting from the exercise of employee warrants. This action directly relates to changes in the company's capital structure and share count. This aligns perfectly with the definition for 'Share Issue/Capital Change' (SHA), which covers updates on new share issues or capital structure changes. Although it is a regulatory announcement, the specific nature of the content points more strongly to SHA than the general 'RNS' fallback.
2016-09-27 Danish
Share Issue/Capital Change 2016
Share Issue/Capital Change Classification · 99% confidence The document is titled "Company Announcement" and details a specific corporate action: an increase in share capital due to the exercise of employee warrants. It specifies the number of shares, the subscription prices, the total proceeds, and the resulting total nominal value of the share capital. This type of announcement directly relates to changes in the company's capital structure and share count. This aligns precisely with the definition for 'Share Issue/Capital Change' (SHA). It is not an earnings release (ER), an interim report (IR), or a general regulatory filing (RNS), as it concerns a specific capital event.
2016-09-27 English
Kapitalforhøjelse i Genmab som følge af udnyttelse af medarbejderwarrants
Share Issue/Capital Change Classification · 100% confidence The document is a formal company announcement from Genmab regarding an increase in share capital resulting from the exercise of employee warrants. It details the number of shares issued, the subscription prices, the impact on total share capital, and the regulatory basis for the disclosure. This fits the definition of a 'Share Issue/Capital Change' (SHA) announcement.
2016-09-27 English
Kapitalforhøjelse i Genmab som følge af udnyttelse af medarbejderwarrants
Share Issue/Capital Change Classification · 100% confidence The document is a corporate announcement from Genmab regarding a capital increase resulting from the exercise of employee warrants. It details the number of shares issued, the subscription prices, and the resulting change in the company's total share capital. This falls under the category of share issuance and capital changes.
2016-09-27 English

Browse filings by year

20 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.